{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T17:13:20Z","timestamp":1779210800683,"version":"3.51.4"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Resistance to neoadjuvant chemoradiotherapy in rectal cancer diminishes survival benefits, potentially due to dysregulated lipid metabolism, though the mechanisms are unclear. Using the MSigDB database and GSE68204 cohort, we identified lipid metabolism genes linked to radiotherapy resistance. We developed resistant cell lines and xenograft models, and through multi-algorithm analysis (SVM-RFE, RF, LASSO), pinpointed key genes. Molecular mechanisms were explored via Western blotting, co-immunoprecipitation, molecular docking, and functional assays, validated in patient-derived organoids. Our study found that radiotherapy-resistant rectal cancer shows a lipid accumulation phenotype, with an inverse relationship between lipid droplet deposition and radiosensitivity in resistant cell models. The multi-algorithm screening identified GDPD5 as a key regulator. Silencing GDPD5 reduced lipid accumulation and increased radiosensitivity. Mechanistically, GDPD5 competes with CD55, disrupting its interaction with EGFR and promoting EGFR nuclear translocation, which suppresses p53 and leads to lipid buildup and radiotherapy resistance in tumors. Clinical samples showed high GDPD5 and low CD55 levels correlate with EGFR nuclear localization. Patient-derived organoids with high GDPD5 also showed increased radiotherapy resistance. Our findings indicate that GDPD5 facilitates EGFR nuclear translocation by binding to CD55, suppressing p53, and causing lipid accumulation and radiotherapy resistance in tumors. Targeting the GDPD5-CD55-EGFR interaction may enhance radiosensitivity.<\/jats:p>","DOI":"10.1038\/s41419-026-08711-3","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T16:36:16Z","timestamp":1775579776000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GDPD5-CD55-EGFR competitive binding axis regulates radioresistance and lipid accumulation in rectal cancer"],"prefix":"10.1038","volume":"17","author":[{"given":"Ruiqiu","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuntian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0248-8826","authenticated-orcid":false,"given":"Qiliang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"8711_CR1","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.6004\/jnccn.2022.0051","volume":"20","author":"AB Benson","year":"2022","unstructured":"Benson AB, Venook AP, Al-Hawary MM, Azad N, Chen YJ, Ciombor KK, et al. Rectal cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20:1139\u201367.","journal-title":"J Natl Compr Canc Netw"},{"key":"8711_CR2","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41575-024-00900-9","volume":"21","author":"Y Kagawa","year":"2024","unstructured":"Kagawa Y, Smith JJ, Fokas E, Watanabe J, Cercek A, Greten FR, et al. Future direction of total neoadjuvant therapy for locally advanced rectal cancer. Nat Rev Gastroenterol Hepatol. 2024;21:444\u201355.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8711_CR3","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1200\/JCO.24.01160","volume":"42","author":"AJ Scott","year":"2024","unstructured":"Scott AJ, Kennedy EB, Berlin J, Brown G, Chalabi M, Cho MT, et al. Management of locally advanced rectal cancer: ASCO guideline. J Clin Oncol. 2024;42:3355\u201375.","journal-title":"J Clin Oncol"},{"key":"8711_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02232-x","volume":"24","author":"D Coelho","year":"2025","unstructured":"Coelho D, Est\u00eav\u00e3o D, Oliveira MJ, Sarmento B. Radioresistance in rectal cancer: can nanoparticles turn the tide?. Mol Cancer. 2025;24:35.","journal-title":"Mol Cancer"},{"key":"8711_CR5","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41575-019-0247-2","volume":"17","author":"AM Buckley","year":"2020","unstructured":"Buckley AM, Lynam-Lennon N, O\u2019Neill H, O\u2019Sullivan J. Targeting hallmarks of cancer to enhance radiosensitivity in gastrointestinal cancers. Nat Rev Gastroenterol Hepatol. 2020;17:298\u2013313.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8711_CR6","doi-asserted-by":"publisher","first-page":"811","DOI":"10.7150\/ijbs.79928","volume":"19","author":"Y Yu","year":"2023","unstructured":"Yu Y, Yu J, Ge S, Su Y, Fan X. Novel insight into metabolic reprogrammming in cancer radioresistance: a promising therapeutic target in radiotherapy. Int J Biol Sci. 2023;19:811\u201328.","journal-title":"Int J Biol Sci"},{"key":"8711_CR7","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1007\/s12094-023-03134-4","volume":"25","author":"D An","year":"2023","unstructured":"An D, Zhai D, Wan C, Yang K. The role of lipid metabolism in cancer radioresistance. Clin Transl Oncol. 2023;25:2332\u201349.","journal-title":"Clin Transl Oncol"},{"key":"8711_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-04931-3","volume":"22","author":"J Liang","year":"2024","unstructured":"Liang J, Liao L, Xie L, Tang W, Yu X, Lu Y, et al. PITPNC1 Suppress CD8(+) T cell immune function and promote radioresistance in rectal cancer by modulating FASN\/CD155. J Transl Med. 2024;22:117.","journal-title":"J Transl Med"},{"key":"8711_CR9","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.tcb.2024.12.010","volume":"35","author":"R Borza","year":"2025","unstructured":"Borza R, Matas-Rico E, Perrakis A, Moolenaar WH. Unlocking the signaling potential of GPI-anchored proteins through lipolytic cleavage. Trends Cell Biol. 2025;35:732\u201344.","journal-title":"Trends Cell Biol"},{"key":"8711_CR10","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.biopha.2018.03.028","volume":"101","author":"C Feng","year":"2018","unstructured":"Feng C, Zhang L, Sun Y, Li X, Zhan L, Lou Y, et al. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer. Biomed Pharmacother. 2018;101:945\u201352.","journal-title":"Biomed Pharmacother"},{"key":"8711_CR11","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/nbm.2766","volume":"25","author":"MD Cao","year":"2012","unstructured":"Cao MD, D\u00f6pkens M, Krishnamachary B, Vesuna F, Gadiya MM, L\u00f8nning PE, et al. Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer. NMR Biomed. 2012;25:1033\u201342.","journal-title":"NMR Biomed"},{"key":"8711_CR12","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/nbm.3106","volume":"27","author":"JP Wijnen","year":"2014","unstructured":"Wijnen JP, Jiang L, Greenwood TR, Cheng M, D\u00f6pkens M, Cao MD, et al. Silencing of the glycerophosphocholine phosphodiesterase GDPD5 alters the phospholipid metabolite profile in a breast cancer model in vivo as monitored by (31) P MRS. NMR Biomed. 2014;27:692\u20139.","journal-title":"NMR Biomed"},{"key":"8711_CR13","doi-asserted-by":"crossref","unstructured":"Luo T, Peng J, Li Q, Zhang Y, Huang Y, Xu L, et al. GDPD5 related to lipid metabolism is a potential prognostic biomarker in neuroblastoma. Int J Mol Sci. 2022;23:13740.","DOI":"10.3390\/ijms232213740"},{"key":"8711_CR14","doi-asserted-by":"crossref","unstructured":"Busato F, Khouzai BE, Mognato M. Biological mechanisms to reduce radioresistance and increase the efficacy of radiotherapy: state of the art. Int J Mol Sci. 2022;23:10211.","DOI":"10.3390\/ijms231810211"},{"key":"8711_CR15","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1158\/0008-5472.CAN-18-3238","volume":"79","author":"A Shen","year":"2019","unstructured":"Shen A, Chen Y, Liu L, Huang Y, Chen H, Qi F, et al. EBF1-mediated upregulation of ribosome assembly factor PNO1 contributes to cancer progression by negatively regulating the p53 signaling pathway. Cancer Res. 2019;79:2257\u201370.","journal-title":"Cancer Res"},{"key":"8711_CR16","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1002\/ptr.6779","volume":"34","author":"X Wang","year":"2020","unstructured":"Wang X, Xu M, Peng Y, Naren Q, Xu Y, Wang X, et al. Triptolide enhances lipolysis of adipocytes by enhancing ATGL transcription via upregulation of p53. Phytother Res. 2020;34:3298\u2013310.","journal-title":"Phytother Res"},{"key":"8711_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41420-022-01241-9","volume":"8","author":"Z Han","year":"2022","unstructured":"Han Z, Liu M, Xie Y, Zeng K, Zhan Z, Chen Y, et al. Derepression of the USP22-FASN axis by p53 loss under oxidative stress drives lipogenesis and tumorigenesis. Cell Death Discov. 2022;8:445.","journal-title":"Cell Death Discov"},{"key":"8711_CR18","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1093\/neuonc\/noac105","volume":"24","author":"J Ding","year":"2022","unstructured":"Ding J, Li X, Khan S, Zhang C, Gao F, Sen S, et al. EGFR suppresses p53 function by promoting p53 binding to DNA-PKcs: a noncanonical regulatory axis between EGFR and wild-type p53 in glioblastoma. Neuro Oncol. 2022;24:1712\u201325.","journal-title":"Neuro Oncol"},{"key":"8711_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13045-015-0137-1","volume":"8","author":"K Zhao","year":"2015","unstructured":"Zhao K, Zhou Y, Qiao C, Ni T, Li Z, Wang X, et al. Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells. J Hematol Oncol. 2015;8:41.","journal-title":"J Hematol Oncol"},{"key":"8711_CR20","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1073\/pnas.0510146103","volume":"103","author":"Y Liu","year":"2006","unstructured":"Liu Y, Bodmer WF. Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines. Proc Natl Acad Sci USA. 2006;103:976\u201381.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8711_CR21","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.7150\/thno.21451","volume":"8","author":"Z Tan","year":"2018","unstructured":"Tan Z, Xiao L, Tang M, Bai F, Li J, Li L, et al. Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy. Theranostics. 2018;8:2329\u201347.","journal-title":"Theranostics"},{"key":"8711_CR22","doi-asserted-by":"publisher","first-page":"20200067","DOI":"10.1259\/bjr.20200067","volume":"93","author":"M Kery","year":"2020","unstructured":"Kery M, Papandreou I. Emerging strategies to target cancer metabolism and improve radiation therapy outcomes. Br J Radiol. 2020;93:20200067.","journal-title":"Br J Radiol"},{"key":"8711_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12944-024-02426-0","volume":"24","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Yang Z, Liu Y, Pei J, Li R, Yang Y. Targeting lipid metabolism: novel insights and therapeutic advances in pancreatic cancer treatment. Lipids Health Dis. 2025;24:12.","journal-title":"Lipids Health Dis"},{"key":"8711_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.03.026","volume":"509","author":"CJ Wang","year":"2021","unstructured":"Wang CJ, Li D, Danielson JA, Zhang EH, Dong Z, Miller KD, et al. Proton pump inhibitors suppress DNA damage repair and sensitize treatment resistance in breast cancer by targeting fatty acid synthase. Cancer Lett. 2021;509:1\u201312.","journal-title":"Cancer Lett"},{"key":"8711_CR25","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1007\/s00204-016-1847-z","volume":"90","author":"R Marchan","year":"2016","unstructured":"Marchan R. GDPD5, a choline-generating enzyme and its novel role in tumor cell migration. Arch Toxicol. 2016;90:3143\u20134.","journal-title":"Arch Toxicol"},{"key":"8711_CR26","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ccell.2016.08.016","volume":"30","author":"E Matas-Rico","year":"2016","unstructured":"Matas-Rico E, van Veen M, Leyton-Puig D, van den Berg J, Koster J, Kedziora KM, et al. Glycerophosphodiesterase GDE2 promotes neuroblastoma differentiation through glypican release and is a marker of clinical outcome. Cancer Cell. 2016;30:548\u201362.","journal-title":"Cancer Cell"},{"key":"8711_CR27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13045-022-01337-w","volume":"15","author":"EY Yu","year":"2022","unstructured":"Yu EY, Cheung NV, Lue NF. Connecting telomere maintenance and regulation to the developmental origin and differentiation states of neuroblastoma tumor cells. J Hematol Oncol. 2022;15:117.","journal-title":"J Hematol Oncol"},{"key":"8711_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40478-022-01376-x","volume":"10","author":"A Westerhaus","year":"2022","unstructured":"Westerhaus A, Joseph T, Meyers AJ, Jang Y, Na CH, Cave C, et al. The distribution and function of GDE2, a regulator of spinal motor neuron survival, are disrupted in amyotrophic lateral sclerosis. Acta Neuropathol Commun. 2022;10:73.","journal-title":"Acta Neuropathol Commun"},{"key":"8711_CR29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semcancer.2021.03.010","volume":"85","author":"Y Liu","year":"2022","unstructured":"Liu Y, Gu W. The complexity of p53-mediated metabolic regulation in tumor suppression. Semin Cancer Biol. 2022;85:4\u201332.","journal-title":"Semin Cancer Biol"},{"key":"8711_CR30","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.celrep.2019.12.074","volume":"30","author":"JG Kang","year":"2020","unstructured":"Kang JG, Lago CU, Lee JE, Park JH, Donnelly MP, Starost MF, et al. A mouse homolog of a human TP53 germline mutation reveals a lipolytic activity of p53. Cell Rep. 2020;30:783\u201392.","journal-title":"Cell Rep"},{"key":"8711_CR31","doi-asserted-by":"publisher","first-page":"100198","DOI":"10.1016\/j.mocell.2025.100198","volume":"48","author":"KY Koo","year":"2025","unstructured":"Koo KY, Moon K, Song HS, Lee MS. Metabolic regulation by p53: implications for cancer therapy. Mol Cells. 2025;48:100198.","journal-title":"Mol Cells"},{"key":"8711_CR32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/cac2.12520","volume":"44","author":"B Song","year":"2024","unstructured":"Song B, Yang P, Zhang S. Cell fate regulation governed by p53: friends or reversible foes in cancer therapy. Cancer Commun. 2024;44:297\u2013360.","journal-title":"Cancer Commun"},{"key":"8711_CR33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41392-020-0150-x","volume":"5","author":"RX Huang","year":"2020","unstructured":"Huang RX, Zhou PK. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduct Target Ther. 2020;5:60.","journal-title":"Signal Transduct Target Ther"},{"key":"8711_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05408-1","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen X, Zhang T, Su W, Dou Z, Zhao D, Jin X, et al. Mutant p53 in cancer: from molecular mechanism to therapeutic modulation. Cell Death Dis. 2022;13:974.","journal-title":"Cell Death Dis"},{"key":"8711_CR35","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41392-021-00648-7","volume":"6","author":"R Huang","year":"2021","unstructured":"Huang R, Zhou PK. DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy. Signal Transduct Target Ther. 2021;6:254.","journal-title":"Signal Transduct Target Ther"},{"key":"8711_CR36","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41588-024-02039-4","volume":"57","author":"JS Funk","year":"2025","unstructured":"Funk JS, Klimovich M, Drangenstein D, Pielhoop O, Hunold P, Borowek A, et al. Deep CRISPR mutagenesis characterizes the functional diversity of TP53 mutations. Nat Genet. 2025;57:140\u201353.","journal-title":"Nat Genet"},{"key":"8711_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06566-4","volume":"23","author":"S Yan","year":"2025","unstructured":"Yan S, Zhan F, He Y, Zhu Y, Ma Z. p53 in colorectal cancer: from a master player to a privileged therapy target. J Transl Med. 2025;23:684.","journal-title":"J Transl Med"},{"key":"8711_CR38","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1158\/2159-8290.CD-23-1362","volume":"14","author":"DP Lane","year":"2024","unstructured":"Lane DP. Mutant p53 gain-of-function in the spotlight: are we suffering a GOF delusion? Cancer Discov. 2024;14:211\u20133.","journal-title":"Cancer Discov"},{"key":"8711_CR39","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41418-022-00989-y","volume":"29","author":"MC Kennedy","year":"2022","unstructured":"Kennedy MC, Lowe SW. Mutant p53: it\u2019s not all one and the same. Cell Death Differ. 2022;29:983\u20137.","journal-title":"Cell Death Differ"},{"key":"8711_CR40","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13045-021-01169-0","volume":"14","author":"J Hu","year":"2021","unstructured":"Hu J, Cao J, Topatana W, Juengpanich S, Li S, Zhang B, et al. Targeting mutant p53 for cancer therapy: direct and indirect strategies. J Hematol Oncol. 2021;14:157.","journal-title":"J Hematol Oncol"},{"key":"8711_CR41","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.cell.2017.08.028","volume":"170","author":"ER Kastenhuber","year":"2017","unstructured":"Kastenhuber ER, Lowe SW. Putting p53 in context. Cell. 2017;170:1062\u201378.","journal-title":"Cell"},{"key":"8711_CR42","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41568-020-0262-1","volume":"20","author":"AJ Levine","year":"2020","unstructured":"Levine AJ. p53: 800 million years of evolution and 40 years of discovery. Nat Rev Cancer. 2020;20:471\u201380.","journal-title":"Nat Rev Cancer"},{"key":"8711_CR43","doi-asserted-by":"publisher","first-page":"e40150","DOI":"10.1016\/j.heliyon.2024.e40150","volume":"10","author":"J Zhu","year":"2024","unstructured":"Zhu J, Wu Z, Shan G, Huang Y, Liang J, Zhan C. Nuclear epidermal growth factor receptor (nEGFR) in clinical treatment. Heliyon. 2024;10:e40150.","journal-title":"Heliyon"},{"key":"8711_CR44","first-page":"1551","volume":"17","author":"CC Yang","year":"2019","unstructured":"Yang CC, Lin LC, Lin YW, Tian YF, Lin CY, Sheu MJ, et al. Higher nuclear EGFR expression is a better predictor of survival in rectal cancer patients following neoadjuvant chemoradiotherapy than cytoplasmic EGFR expression. Oncol Lett. 2019;17:1551\u20138.","journal-title":"Oncol Lett"},{"key":"8711_CR45","doi-asserted-by":"publisher","first-page":"e3002547","DOI":"10.1371\/journal.pbio.3002547","volume":"22","author":"B Ewen-Campen","year":"2024","unstructured":"Ewen-Campen B, Perrimon N. Wnt signaling modulates the response to DNA damage in the Drosophila wing imaginal disc by regulating the EGFR pathway. PLoS Biol. 2024;22:e3002547.","journal-title":"PLoS Biol"},{"key":"8711_CR46","doi-asserted-by":"publisher","first-page":"215935","DOI":"10.1016\/j.canlet.2022.215935","volume":"551","author":"R Bharti","year":"2022","unstructured":"Bharti R, Dey G, Lin F, Lathia J, Reizes O. CD55 in cancer: complementing functions in a non-canonical manner. Cancer Lett. 2022;551:215935.","journal-title":"Cancer Lett"},{"key":"8711_CR47","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1152\/physrev.00027.2021","volume":"102","author":"T Lala","year":"2022","unstructured":"Lala T, Hall RA. Adhesion G protein-coupled receptors: structure, signaling, physiology, and pathophysiology. Physiol Rev. 2022;102:1587\u2013624.","journal-title":"Physiol Rev"},{"key":"8711_CR48","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1084\/jem.20170438","volume":"214","author":"C Saygin","year":"2017","unstructured":"Saygin C, Wiechert A, Rao VS, Alluri R, Connor E, Thiagarajan PS, et al. CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors. J Exp Med. 2017;214:2715\u201332.","journal-title":"J Exp Med"},{"key":"8711_CR49","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/path.4991","volume":"244","author":"TH Leung","year":"2018","unstructured":"Leung TH, Tang HW, Siu MK, Chan DW, Chan KK, Cheung AN, et al. Human papillomavirus E6 protein enriches the CD55(+) population in cervical cancer cells, promoting radioresistance and cancer aggressiveness. J Pathol. 2018;244:151\u201363.","journal-title":"J Pathol"},{"key":"8711_CR50","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.1016\/j.celrep.2018.11.093","volume":"25","author":"MM Olcina","year":"2018","unstructured":"Olcina MM, Balanis NG, Kim RK, Aksoy BA, Kodysh J, Thompson MJ, et al. Mutations in an innate immunity pathway are associated with poor overall survival outcomes and hypoxic signaling in cancer. Cell Rep. 2018;25:3721\u201332.","journal-title":"Cell Rep"},{"key":"8711_CR51","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.2147\/DDDT.S182337","volume":"12","author":"G Li","year":"2018","unstructured":"Li G, Yin Q, Ji H, Wang Y, Liu H, Jiang L, et al. A study on screening and antitumor effect of CD55-specific ligand peptide in cervical cancer cells. Drug Des Devel Ther. 2018;12:3899\u2013912.","journal-title":"Drug Des Devel Ther"},{"key":"8711_CR52","doi-asserted-by":"crossref","unstructured":"Yang L, Wei W, Yuan X, Guo E, Peng P, Wang J, et al. Targeting DNA damage repair to enhance antitumor immunity in radiotherapy: mechanisms and opportunities. Int J Mol Sci. 2025;26:3743.","DOI":"10.3390\/ijms26083743"},{"key":"8711_CR53","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00109-019-01863-0","volume":"98","author":"AD Khwairakpam","year":"2020","unstructured":"Khwairakpam AD, Banik K, Girisa S, Shabnam B, Shakibaei M, Fan L, et al. The vital role of ATP citrate lyase in chronic diseases. J Mol Med. 2020;98:71\u201395.","journal-title":"J Mol Med"},{"key":"8711_CR54","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/mco2.27","volume":"2","author":"Y Fu","year":"2021","unstructured":"Fu Y, Zou T, Shen X, Nelson PJ, Li J, Wu C, et al. Lipid metabolism in cancer progression and therapeutic strategies. MedComm. 2021;2:27\u201359.","journal-title":"MedComm"},{"key":"8711_CR55","doi-asserted-by":"publisher","first-page":"740","DOI":"10.20892\/j.issn.2095-3941.2020.0219","volume":"17","author":"J Chen","year":"2020","unstructured":"Chen J, Zhang F, Ren X, Wang Y, Huang W, Zhang J, et al. Targeting fatty acid synthase sensitizes human nasopharyngeal carcinoma cells to radiation via downregulating frizzled class receptor 10. Cancer Biol Med. 2020;17:740\u201352.","journal-title":"Cancer Biol Med"},{"key":"8711_CR56","doi-asserted-by":"crossref","unstructured":"Kubik J, Humeniuk E, Adamczuk G, Madej-Czerwonka B, Korga-Plewko A. Targeting energy metabolism in cancer treatment. Int J Mol Sci. 2022;23:5572.","DOI":"10.3390\/ijms23105572"},{"key":"8711_CR57","doi-asserted-by":"publisher","first-page":"114718","DOI":"10.1016\/j.bcp.2021.114718","volume":"192","author":"YS Kwon","year":"2021","unstructured":"Kwon YS, Lee MG, Baek J, Kim NY, Jang H, Kim S. Acyl-CoA synthetase-4 mediates radioresistance of breast cancer cells by regulating FOXM1. Biochem Pharmacol. 2021;192:114718.","journal-title":"Biochem Pharmacol"},{"key":"8711_CR58","doi-asserted-by":"crossref","unstructured":"Nistic\u00f2 C, Pagliari F, Chiarella E, Fernandes Guerreiro J, Marafioti MG, Aversa I, et al. Lipid droplet biosynthesis impairment through DGAT2 inhibition sensitizes MCF7 breast cancer cells to radiation. Int J Mol Sci. 2021;22:10102.","DOI":"10.3390\/ijms221810102"},{"key":"8711_CR59","doi-asserted-by":"publisher","first-page":"e1700223","DOI":"10.1002\/pmic.201700223","volume":"19","author":"C Zhang","year":"2019","unstructured":"Zhang C, Liu P. The new face of the lipid droplet: lipid droplet proteins. Proteomics. 2019;19:e1700223.","journal-title":"Proteomics"},{"key":"8711_CR60","doi-asserted-by":"publisher","first-page":"e2105222","DOI":"10.1002\/advs.202105222","volume":"9","author":"H Liu","year":"2022","unstructured":"Liu H, Du J, Chao S, Li S, Cai H, Zhang H, et al. Fusobacterium nucleatum promotes colorectal cancer cell to acquire stem cell-like features by manipulating lipid droplet-mediated numb degradation. Adv Sci. 2022;9:e2105222.","journal-title":"Adv Sci"},{"key":"8711_CR61","doi-asserted-by":"publisher","first-page":"eabj0140","DOI":"10.1126\/sciimmunol.abj0140","volume":"7","author":"D D\u00f6rr","year":"2022","unstructured":"D\u00f6rr D, Obermayer B, Weiner JM, Zimmermann K, Anania C, Wagner LK, et al. C\/EBP\u03b2 regulates lipid metabolism and Pparg isoform 2 expression in alveolar macrophages. Sci Immunol. 2022;7:eabj0140.","journal-title":"Sci Immunol"},{"key":"8711_CR62","doi-asserted-by":"publisher","first-page":"e03473","DOI":"10.1002\/advs.202503473","volume":"12","author":"H Liu","year":"2025","unstructured":"Liu H, Jing L, Li Y, Zhou J, Cui X, Li S, et al. Lipid droplet-organized MDM2-mediated P53 degradation: a metabolic switch governing diet-driven tumor progression. Adv Sci. 2025;12:e03473.","journal-title":"Adv Sci"},{"key":"8711_CR63","first-page":"2316","volume":"141","author":"A Calabria","year":"2023","unstructured":"Calabria A, Cipriani C, Spinozzi G, Rudilosso L, Esposito S, Benedicenti F, et al. Intrathymic AAV delivery results in therapeutic site-specific integration at TCR loci in mice. Blood. 2023;141:2316\u201329.","journal-title":"Blood"},{"key":"8711_CR64","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/j.cell.2021.03.025","volume":"184","author":"JK Nu\u00f1ez","year":"2021","unstructured":"Nu\u00f1ez JK, Chen J, Pommier GC, Cogan JZ, Replogle JM, Adriaens C, et al. Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing. Cell. 2021;184:2503\u201319.","journal-title":"Cell"},{"key":"8711_CR65","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1148\/radiol.2021204325","volume":"300","author":"H Jiang","year":"2021","unstructured":"Jiang H, Chen HC, Lafata KJ, Bashir MR. Week 4 liver fat reduction on MRI as an early predictor of treatment response in participants with nonalcoholic steatohepatitis. Radiology. 2021;300:361\u20138.","journal-title":"Radiology"},{"key":"8711_CR66","doi-asserted-by":"publisher","first-page":"8974","DOI":"10.1007\/s00330-023-09864-x","volume":"33","author":"PA Kupczyk","year":"2023","unstructured":"Kupczyk PA, Kurt D, Endler C, Luetkens JA, Kukuk GM, Fronhoffs F, et al. MRI proton density fat fraction for estimation of tumor grade in steatotic hepatocellular carcinoma. Eur Radiol. 2023;33:8974\u201385.","journal-title":"Eur Radiol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08711-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08711-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08711-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T17:03:01Z","timestamp":1779210181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08711-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8711"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08711-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"27 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"In vivo experiments met relevant ethical guidelines for animal research, followed AstraZeneca\u2019s global bioethics policy, and had the approval of the ethical committee of Soochow University (Approval Number: SUDA202411A1189). All human tissue research in this study had the approval of the ethics committees of the Second Affiliated Hospital of Soochow University (Approval Number: JD-LK2022167-IR02). Informed consent was obtained from all participants involved in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"492"}}